Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4070 | Ordered by Date (descending)
1 2 3 ... 39 40 41  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sygnature Discovery Ltd.. (2/15/19). "Press Release: Sygnature Discovery Starts 2019 with Two Senior Appointments – Dr Allan Jordan and Ms Louisa Jordison". Nottingham. 2019-02-15
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. 2019-02-11
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. 2019-02-07
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. 2019-02-06
GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. 2019-02-06
Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. 2019-02-04
Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". 2019-02-04
Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. 2019-02-04
[iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. 2019-02-01
MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. 2019-01-31
Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. 2019-01-28
Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. 2019-01-28
Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. 2019-01-23
GlaxoSmithKline plc. (1/22/19). "Press Release: GSK Completes Acquisition of Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2019-01-22
EBD Group. (1/22/19). "Press Release: Biotech Showcase Celebrates Record Attendance by Life Science Investors, CEOs". New York, NY, San Francisco, CA & Carlsbad, CA. 2019-01-22
Wren Therapeutics Ltd.. (1/22/19). "Press Release: Wren Therapeutics Completes £18 Million Series A Financing". Cambridge. 2019-01-22
Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels. 2019-01-22
GlaxoSmithKline plc. (1/21/19). "Press Release: GSK Announces Succession Plan to Appoint New Chairman". 2019-01-21
Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. 2019-01-21
Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. 2019-01-18
Immunocore Ltd.. (1/15/19). "Press Release: Immunocore Names David Berman as Head of R&D". Oxford & Conshohocken, PA. 2019-01-15
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
Solentim Ltd.. (1/14/19). "Press Release: Solentim and ATUM Announce Technology Collaboration to Enable Rapid, High Expression, Stable Cell Line Development". Bournemouth. 2019-01-14
Deyton Bell Ltd.. (1/13/19). "Press Release: Deyton Bell Announce Exciting Further Expansion – Harriet Fear Joins the Team". 2019-01-13
[iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2019-01-11
AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". 2019-01-07
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. 2019-01-07
F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. 2019-01-07
Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices". 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". 2019-01-07
Evotec AG. (1/7/19). "Press Release: Evotec Invests in Financing Round of Exscientia". Hamburg. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". 2019-01-07
Immunocore Ltd.. (1/4/19). "Press Release: Immunocore Appoints Bahija Jallal as Chief Executive Officer". Oxford & Conshohocken, PA. 2019-01-04
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. 2019-01-03
ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. 2019-01-03
Vedanta Biosciences. (12/24/18). "Press Release: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates". Cambridge, MA. 2018-12-24
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. 2018-12-21
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2018-12-20
Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London. 2018-12-17
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. 2018-12-13
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford. 2018-12-11
Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA. 2018-12-10
MyNewGut Project. (12/10/18). "Press Release: Gut Microbiota Linked to Obesity and Mental Disorders, EU-funded Project »MyNewGut« Finds". 2018-12-10
AstraZeneca plc. (12/10/18). "Press Release: AstraZeneca and Cancer Research UK Launch Functional Genomics Centre to Accelerate the Discovery of New Medicines". 2018-12-10
Lonza Group AG. (12/10/18). "Press Release: Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution". Basel & Guangzhou. 2018-12-10
Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford. 2018-12-10
AstraZeneca plc. (12/7/18). "Press Release: Update on the Phase III EAGLE Trial of Imfinzi and Tremelimumab in Advanced Head and Neck Cancer". 2018-12-07
Genomics England Ltd.. (12/5/18). "Press Release: The UK Has Sequenced 100,000 Whole Genomes in the NHS. Pioneering 100,000 Genomes Project Reaches Its Goal and Thanks All Involved". 2018-12-05
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK Reaches Agreement to Acquire Tesaro, an Oncology Focused Biopharmaceutical Company". London. 2018-12-03
GlaxoSmithKline plc. (12/3/18). "Press Release: GSK to Divest Horlicks and other Consumer Healthcare Nutrition Products to Unilever". 2018-12-03
Igem Therapeutics Ltd.. (11/30/18). "Press Release: Igem Therapeutics Announces Final Close of £5 Million Series A Financing Round". London. 2018-11-30
AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. 2018-11-29
Biocartis Group N.V.. (11/29/18). "Press Release: Biocartis and AstraZeneca Enter into Agreement Aimed at Faster Lung Cancer Biomarker Results". Mechelen. 2018-11-29
Sygnature Discovery Ltd.. (11/27/18). "Press Release: Sygnature Discovery Establishes US Office in Cambridge, MA". Nottingham & Cambridge, MA. 2018-11-27
Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". 2018-11-27
Inkef Capital B.V.. (11/27/18). "Press Release: Inkef Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund". Amsterdam. 2018-11-27
OMass Therapeutics Ltd.. (11/27/18). "Press Release: OMass Therapeutics Expands Its Senior Leadership Team". 2018-11-27
Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London. 2018-11-26
Immune Regulation Ltd.. (11/26/18). "Press Release: Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104". Stevenage. 2018-11-26
Fluidic Analytics Ltd.. (11/26/18). "Press Release: Fluidic Analytics Raises $31m to Launch Two New Products in Lab Tools Pipeline and Unlock Biology Behind Major Diseases". 2018-11-26
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. 2018-11-26
LGC Ltd.. (11/26/18). "Press Release: LGC Acquires Seracare Life Sciences, Strengthening Its Position in Clinical Quality Control Tools". 2018-11-26
GlaxoSmithKline plc. (11/26/18). "Press Release: Juluca (dolutegravir/rilpivirine), the First Single Pill, 2-drug Regimen, for the Maintenance Treatment of HIV, Granted Marketing Approval by Japan Ministry of Health, Labour and Welfare". London. 2018-11-26
Oxford BioMedica plc. (11/23/18). "Press Release: Oxford BioMedica Announces New Digital Framework Initiative to Streamline the Production of Next-generation Medicines with Cash Injection from Innovate UK". Oxford. 2018-11-23
GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London. 2018-11-22
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate Announces Change of Name to Immune Regulation, Strengthening of the Board and Successful Fundraise". 2018-11-22
F2G Ltd.. (11/22/18). "Press Release: EU Supports F2G Biotech in Austria with EUR 24 Million for Antifungal Research and Innovation". Luxembourg. 2018-11-22
OMass Therapeutics Ltd.. (11/21/18). "Press Release: OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines". Oxford. 2018-11-21
Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert. 2018-11-21
Immunocore Ltd.. (11/19/18). "Press Release: Immunocore to Co-develop IMC-C103C, a T Cell Redirecting Bi-specific Biologic, with Genentech". Oxford & Conshohocken, PA. 2018-11-19
Inflazome Ltd.. (11/19/18). "Press Release: Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept". Dublin & Cambridge. 2018-11-19
Agilent Technologies Inc.. (11/16/18). "Press Release: Agilent Expands Cell Analysis R&D Capabilities in Ireland. New Facility Incorporates Recently Acquired Luxcel Biosciences". Santa Clara, CA. 2018-11-16
Goodwin Procter LLC. (11/15/18). "Press Release: Goodwin Adds Life Sciences and Technology Partner Sophie McGrath in London". London. 2018-11-15
Genomics England Ltd.. (11/15/18). "Press Release: Helomics Partners with Genomics England’s Discovery Forum to Drive Precision Medicine for Ovarian Cancer". 2018-11-15
Virion Biotherapeutics Ltd.. (11/14/18). "Press Release: Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections". London. 2018-11-14
Bruker Corporation. (11/14/18). "Press Release: Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH". Billerica. 2018-11-14
Hox Therapeutics Ltd.. (11/13/18). "Press Release: Hox Therapeutics Appoints Karl Keegan as Chief Executive Officer". Guildford, Surrey. 2018-11-13
Life Sciences Partners (LSP). (11/12/18). "Press Release: LSP Raises Record €750 Million in 10 Months for Life Sciences Innovations [NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY JURISDICTION WHERE U 2018-11-12
Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. 2018-11-12
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London. 2018-11-12
Harpoon Therapeutics, Inc.. (11/11/18). "Press Release: Harpoon Therapeutics Announces Closing of $70M Series C Financing". South San Francisco, CA. 2018-11-11
Sygnature Discovery Ltd.. (11/8/18). "Press Release: Sygnature Discovery Announces Multi-target Drug Discovery Deal with Sitryx Therapeutics". 2018-11-08
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". 2018-11-07
AstraZeneca plc. (11/6/18). "Press Release: Divestment of Rights to Alvesco, Omnaris and Zetonna to Covis Pharma". 2018-11-06
Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". 2018-11-06
Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-11-06
Orchard Therapeutics Ltd.. (11/5/18). "Press Release: Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option". Boston, MA & London. 2018-11-05
Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. 2018-11-05
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. 2018-11-02
1 2 3 ... 39 40 41  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px

» top